25 related articles for article (PubMed ID: 2118728)
1.
Cui X; Wang J; Li Y; Couse ZG; Risoleo TF; Moayeri M; Leppla SH; Malide D; Yu ZX; Eichacker PQ
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H36-H51. PubMed ID: 33064559
[No Abstract] [Full Text] [Related]
2. Cysteinyl leukotrienes impair hypoxic pulmonary vasoconstriction in endotoxemic mice.
Petersen B; Austen KF; Bloch KD; Hotta Y; Ichinose F; Kanaoka Y; Zapol WM
Anesthesiology; 2011 Oct; 115(4):804-11. PubMed ID: 21934409
[TBL] [Abstract][Full Text] [Related]
3. Can Hyperperfusion of Nonaerated Lung Explain COVID-19 Hypoxia?
Herrmann J; Mori V; Bates JHT; Suki B
Res Sq; 2020 Jun; ():. PubMed ID: 32702716
[TBL] [Abstract][Full Text] [Related]
4. A mitochondrial redox oxygen sensor in the pulmonary vasculature and ductus arteriosus.
Dunham-Snary KJ; Hong ZG; Xiong PY; Del Paggio JC; Herr JE; Johri AM; Archer SL
Pflugers Arch; 2016 Jan; 468(1):43-58. PubMed ID: 26395471
[TBL] [Abstract][Full Text] [Related]
5. Increased eicosanoid levels in the Sugen/chronic hypoxia model of severe pulmonary hypertension.
Al-Husseini A; Wijesinghe DS; Farkas L; Kraskauskas D; Drake JI; Van Tassel B; Abbate A; Chalfant CE; Voelkel NF
PLoS One; 2015; 10(3):e0120157. PubMed ID: 25785937
[TBL] [Abstract][Full Text] [Related]
6. Hypoxic pulmonary vasoconstriction.
Sylvester JT; Shimoda LA; Aaronson PI; Ward JP
Physiol Rev; 2012 Jan; 92(1):367-520. PubMed ID: 22298659
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.
Voelkel NF; Tuder RM; Wade K; Höper M; Lepley RA; Goulet JL; Koller BH; Fitzpatrick F
J Clin Invest; 1996 Jun; 97(11):2491-8. PubMed ID: 8647941
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia and the pulmonary circulation.
Anand IS
Thorax; 1994; 49 Suppl(Suppl):S19-24. PubMed ID: 7974321
[No Abstract] [Full Text] [Related]
9. Exploration of the pulmonary circulation. Festschrift to Professor Donald Heath.
Thorax; 1994; 49 Suppl(Suppl):S1-62. PubMed ID: 7974319
[No Abstract] [Full Text] [Related]
10. Release of leukotrienes into the perfusate of calcium-ionophore stimulated rabbit lungs. Influence of 5-lipoxygenase inhibitors.
Schulz R; Seeger W
Biochem Pharmacol; 1986 Jan; 35(2):183-93. PubMed ID: 3002385
[TBL] [Abstract][Full Text] [Related]
11. Leukotrienes: possible mediators in bronchial asthma.
Piper PJ
Eur J Respir Dis Suppl; 1983; 129():45-64. PubMed ID: 6317422
[TBL] [Abstract][Full Text] [Related]
12. Role of peptidoleukotrieens in hypoxic pulmonary vasoconstriction in rats.
McDonnell TJ; Westcott JY; Czartolomna J; Voelkel NF
Am J Physiol; 1990 Sep; 259(3 Pt 2):H751-8. PubMed ID: 2118728
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of rat lung glutathione synthesis attenuates hypoxic pulmonary vasoconstriction and the associated leukotriene C4 production.
Peters-Golden M; Shelly C; Morganroth ML
Am Rev Respir Dis; 1989 Nov; 140(5):1210-5. PubMed ID: 2817583
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene C4 production during hypoxic pulmonary vasoconstriction in isolated rat lungs.
Morganroth ML; Stenmark KR; Zirrolli JA; Mauldin R; Mathias M; Reeves JT; Murphy RC; Voelkel NF
Prostaglandins; 1984 Dec; 28(6):867-75. PubMed ID: 6522621
[TBL] [Abstract][Full Text] [Related]
15. Effects of nordihydroguaiuretic acid on sulfidopeptide leukotriene activity and hypoxic pulmonary vasoconstriction in the isolated sheep lung.
Schnader J; Undem B; Peters SP; Sylvester JT
Prostaglandins; 1993 Jul; 46(1):5-19. PubMed ID: 8378542
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]